11,639 results
Search Results
102. Basic fibroblast growth factor as a mediator of the effects of glutamate in the development of long-lasting sensitization to stimulant drugs: studies in the rat
103. Alcohol-induced locomotor activation in C57BL/6J, A/J, and AXB/BXA recombinant inbred mice: strain distribution patterns and quantitative trait loci analysis
104. Effects of dopaminergic drugs on delayed reward as a measure of impulsive behavior in rats
105. Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine
106. Effect of central 5-hydroxytryptamine depletion on changeover behaviour in concurrent schedules of reinforcement
107. Psychopharmacology of conditioned reward: evidence for a rewarding signal at D1-like dopamine receptors
108. Neurobiological similarities in antidepressant sleep deprivation and psychostimulant use: a psychostimulant theory of antidepressant sleep deprivation
109. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation
110. Precipitating factors in spontaneous recurrence of methamphetamine psychosis
111. Benzodiazepine self-administration in humans and laboratory animals – implications for problems of long-term use and abuse
112. Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data
113. Computer-administered clinical rating scales A review: A review
114. Polysomnographic effects of hypnotic drugs: A review
115. Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers
116. Effects of the 5-HT1A receptor agonist flesinoxan in panic disorder
117. Effects of the putative dopamine D3 receptor agonist 7-OH-DPAT in rhesus monkeys trained to discriminate cocaine from saline
118. Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome
119. Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice
120. Effects of trepelennamine on brain monoamine turnover in morphine dependent and abstinent mice
121. Behavioural consequences of maternal exposure to natural cannabinoids in rats
122. Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression
123. The scientific case that nicotine is addictive
124. Kavapyrone enriched extract fromPiper methysticum as modulator of the GABA binding site in different regions of rat brain
125. Stress-induced changes in respiratory quotient, energy expenditure and locomotor activity in rats: effects of midazolam
126. Nitrous oxide anxiolytic effect in mice in the elevated plus maze: Mediation by benzodiazepine receptors
127. Evidence that nicotine can acutely desensitize central nicotinic acetylcholinergic receptors
128. Selective antagonism of dopamine D1 and D2 receptors does not block the development of behavioral sensitization to cocaine
129. Research diagnostic criteria for drug-induced akathisia: conceptualization, rationale and proposal
130. Buspirone, gepirone, ipsapirone, and zalospirone have distinct effects on the differential-reinforcement-of-low-rate 72-s schedule when compared with 5-HTP and diazepam
131. Sequence-specific effects of neurokinin substance P on memory, reinforcement, and brain dopamine activity
132. Does the effect of central 5-hydroxytryptamine depletion on timing depend on motivational change?
133. Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supporting neurochemical and behavioural evidence
134. Glutamate: its role in learning, memory, and the aging brain
135. The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system
136. Clinical investigation of monoamine neurotransmitter interactions
137. Effects of daily SKF 38393, quinpirole, and SCH 23390 treatments on locomotor activity and subsequent sensitivity to apomorphine
138. 5-HT2 and D2 dopamine receptor occupancy in the living human brain: A PET study with risperidone
139. Psychopharmacological properties of calcium channel inhibitors
140. Psychopharmacological effects of smoking a cigarette with typical “tar” and carbon monoxide yields but minimal nicotine
141. Comparison of error patterns produced by scopolamine and MK-801 on repeated acquisition and transition baselines
142. Alcohol and “bursts” of aggressive behavior: ethological analysis of individual differences in rats
143. Effects of selective D1 and D2 dopamine antagonists on the development of behavioral sensitization to apomorphine
144. Behavioural and electroencephalographic interactions between haloperidol and PCP/sigma ligands in the rat
145. Prospective study of factors influencing the development of craving associated with smoking cessation
146. Effect of buspirone on cigarette withdrawal symptoms and short-term abstinence rates in a smokers clinic
147. Importance of delta opioid receptors in maintaining high alcohol drinking
148. Enhancement of imipramine-induced rat brain β-adrenoreceptor desensitization by subacute co-administration of trazodone, zimelidine, quipazine or 5-hydroxytryptophan
149. Serotonin, memory, and the aging brain
150. Smoking-associated changes in the serotonergic systems of discrete regions of human brain
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.